Evidence map›Paper›PMID 31341975›Full record

ArticleClinical and translational radiation oncology2019

Individual lymph nodes: "See it and Zap it".

Dennis Winkel, Anita M Werensteijn-Honingh, Petra S Kroon, Wietse S C Eppinga, Gijsbert H Bol, Martijn P W Intven, Hans C J de Boer, Louk M W Snoeren, Jochem Hes, Bas W Raaymakers and 1 more

Abstract read
In one paragraph

Article in Clinical and translational radiation oncology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Stereotactic body radiotherapy of lymph node metastases under MR-guidance: First clinical results and patient-reported outcomes.Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2022
    Observational
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Adaptive radiotherapy: The Elekta Unity MR-linac concept.Clinical and translational radiation oncology · 2019
    Article
  16. Online MR-guided radiotherapy - A new era in radiotherapy.Clinical and translational radiation oncology · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Dennis WinkelDepartment of Radiotherapy, University Medical Center, Utrecht, The Netherlands.
Anita M Werensteijn-HoninghDepartment of Radiotherapy, University Medical Center, Utrecht, The Netherlands.
Petra S KroonDepartment of Radiotherapy, University Medical Center, Utrecht, The Netherlands.
Wietse S C EppingaDepartment of Radiotherapy, University Medical Center, Utrecht, The Netherlands.
Gijsbert H BolDepartment of Radiotherapy, University Medical Center, Utrecht, The Netherlands.
Martijn P W IntvenDepartment of Radiotherapy, University Medical Center, Utrecht, The Netherlands.
Hans C J de BoerDepartment of Radiotherapy, University Medical Center, Utrecht, The Netherlands.
Louk M W SnoerenDepartment of Radiotherapy, University Medical Center, Utrecht, The Netherlands.
Jochem HesDepartment of Radiotherapy, University Medical Center, Utrecht, The Netherlands.
Bas W RaaymakersDepartment of Radiotherapy, University Medical Center, Utrecht, The Netherlands.
Ina M Jürgenliemk-SchulzDepartment of Radiotherapy, University Medical Center, Utrecht, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background and purposeWith magnetic resonance imaging (MRI)-guided radiotherapy systems such as the 1.5T MR-linac the daily anatomy can be visualized before, during and after radiation delivery. With these treatment systems, seeing metastatic nodes with MRI and zapping them with stereotactic body radiotherapy (SBRT) comes into reach. The purpose of this study is to investigate different online treatment planning strategies and to determine the planning target volume (PTV) margin needed for adequate target coverage when treating lymph node oligometastases with SBRT on the 1.5T MR-linac. MATERIALS AND

methodsTen patients were treated for single pelvic or para-aortic lymph node metastases on the 1.5T MR-linac with a prescribed dose of 5x7Gy with a 3 mm isotropic GTV- PTV margin. Based on the daily MRI and actual contours, a completely new treatment plan was generated for each session (adapt to shape, ATS). These were compared with plans optimized on pre-treatment CT contours after correcting for the online target position (adapt to position, ATP). At the end of each treatment session, a post-radiation delivery MRI was acquired on which the GTV was delineated to evaluate the GTV coverage and PTV margins.

resultsThe median PTV V

conclusionFor pelvic and para-aortic metastatic lymph nodes, online MRI-guided adaptive treatment planning results in adequate PTV and GTV coverage when taking the actual patient anatomy into account (ATS). Generally, GTV coverage remained adequate throughout the treatment session for both adaptive planning strategies. "Seeing and zapping" metastatic lymph nodes comes within reach for MRI-guided SBRT.

Indexed as

Lymph node oligometastasesMRI-guided radiotherapyMR-linacOnline plan adaptationRadiotherapy

Identifiers

PMID31341975
PMCPMC6630103

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.